SBI Life is approaching a critical zone on the weekly chart: the lower boundary of its multi-year ascending channel.
The stock has broadly respected this rising channel since 2018, with several major rallies and corrections unfolding within its boundaries.
After reaching a high near ₹2,129, the stock has corrected sharply and is now trading around ₹1,685.
The key zone I'm watching is ₹1,650–₹1,700.
📊 Why this zone matters
This is not just an ordinary support level. It represents the lower boundary of a long-term rising channel that has guided the stock's broader trend for years.
🟢 Scenario 1: Channel support holds
If buyers defend this zone and price forms a convincing reversal structure, a recovery toward ₹1,800–₹1,900 could be the first step.
A sustained recovery could bring ₹2,000–₹2,130 back into focus.
The bullish case, however, needs confirmation from price action.
🔴 Scenario 2: Channel breakdown
If SBI Life decisively breaks below the lower trendline and fails to reclaim it, the long-term structure could weaken significantly.
In that case, lower zones around ₹1,500 and ₹1,300 could become relevant areas to monitor.
🧠 What about the life insurance sector?
SBI Life delivered strong Q1 FY27 results, with net premium income rising approximately 17% year over year and value of new business growing 29%.
However, September's industry data showed slower individual premium growth, with SBI Life's individual APE declining 2.3% year over year.
This suggests that the business backdrop remains constructive in some areas, but near-term growth momentum deserves close monitoring.
🎯 My takeaway
I'm not treating this as a blind buying opportunity.
I'm watching whether the stock can defend its long-term channel and establish a bullish reversal.
₹1,650–₹1,700 is the decision zone.
If the channel holds, a recovery setup could emerge. If it breaks decisively, the long-term structure needs to be reassessed.
#SBILife #SBILifeInsurance #NSE #IndianStockMarket #TechnicalAnalysis #PriceAction #TrendlineSupport #SwingTrading #StockMarketIndia #LifeInsurance
The stock has broadly respected this rising channel since 2018, with several major rallies and corrections unfolding within its boundaries.
After reaching a high near ₹2,129, the stock has corrected sharply and is now trading around ₹1,685.
The key zone I'm watching is ₹1,650–₹1,700.
📊 Why this zone matters
This is not just an ordinary support level. It represents the lower boundary of a long-term rising channel that has guided the stock's broader trend for years.
🟢 Scenario 1: Channel support holds
If buyers defend this zone and price forms a convincing reversal structure, a recovery toward ₹1,800–₹1,900 could be the first step.
A sustained recovery could bring ₹2,000–₹2,130 back into focus.
The bullish case, however, needs confirmation from price action.
🔴 Scenario 2: Channel breakdown
If SBI Life decisively breaks below the lower trendline and fails to reclaim it, the long-term structure could weaken significantly.
In that case, lower zones around ₹1,500 and ₹1,300 could become relevant areas to monitor.
🧠 What about the life insurance sector?
SBI Life delivered strong Q1 FY27 results, with net premium income rising approximately 17% year over year and value of new business growing 29%.
However, September's industry data showed slower individual premium growth, with SBI Life's individual APE declining 2.3% year over year.
This suggests that the business backdrop remains constructive in some areas, but near-term growth momentum deserves close monitoring.
🎯 My takeaway
I'm not treating this as a blind buying opportunity.
I'm watching whether the stock can defend its long-term channel and establish a bullish reversal.
₹1,650–₹1,700 is the decision zone.
If the channel holds, a recovery setup could emerge. If it breaks decisively, the long-term structure needs to be reassessed.
#SBILife #SBILifeInsurance #NSE #IndianStockMarket #TechnicalAnalysis #PriceAction #TrendlineSupport #SwingTrading #StockMarketIndia #LifeInsurance
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.